Concepedia

Brenda McDermott

BM

3

Publications

181

Citations

3

H-Index

2006

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Brenda McDermott is an author at AstraZeneca (United Kingdom) specializing in tumor microenvironment, radiation oncology, and medicine.

Top concepts

Publications per year

2006–2013

3

Publications

3

A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models

Jeffrey L. Brown, Zhe Cao, Maria Pinzon-Ortiz et al. · Molecular Cancer Therapeutics · 2010 · 150 citations · Full text

, , +16

Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer

Naomi Laing, Brenda McDermott, Shenghua Wen et al. · Molecular Pharmacology · 2013 · 18 citations

An Immunoglobulin Fusion Protein Based on the gp120-CD4 Receptor Complex Potently Inhibits Human Immunodeficiency Virus Type 1 <i>in Vitro</i>

John Vu, Timothy Fouts, Katherine Bobb et al. · AIDS Research and Human Retroviruses · 2006 · 13 citations

Rows per page

1–3 of 3